HAKIM, F.; WANG, Y.; ZHANG, S. X. L. Fragmented Sleep Accelerates Tumor Growth and Progression through Recruitment of Tumor-Associated Macrophages and TLR4 Signaling. Cancer Research. 2014-03-01, roč. 74, čís. 5, s. 1329–1337. Dostupné online [cit. 2020-01-20]. ISSN0008-5472. doi:10.1158/0008-5472.CAN-13-3014. PMID24448240. (anglicky)
LU, Yong-Chen; YEH, Wen-Chen; OHASHI, Pamela S. LPS/TLR4 signal transduction pathway. Cytokine. 2008-05, roč. 42, čís. 2, s. 145–151. Dostupné online [cit. 2020-01-19]. doi:10.1016/j.cyto.2008.01.006. (anglicky)
O'NEILL, Luke A. J.; GOLENBOCK, Douglas; BOWIE, Andrew G. The history of Toll-like receptors — redefining innate immunity. Nature Reviews Immunology. 2013-06, roč. 13, čís. 6, s. 453–460. Dostupné online [cit. 2020-01-20]. ISSN1474-1733. doi:10.1038/nri3446. (anglicky)
BEUTLER, B.; REHLI, M. Evolution of the TIR, Tolls and TLRs: Functional Inferences from Computational Biology. Příprava vydání Bruce Beutler, Hermann Wagner. Svazek 270. Berlin, Heidelberg: Springer Berlin Heidelberg Dostupné online. ISBN978-3-642-63975-3, ISBN978-3-642-59430-4. doi:10.1007/978-3-642-59430-4_1. S.1–21. DOI: 10.1007/978-3-642-59430-4_1.
QUACH, Hélène; WILSON, Daniel; LAVAL, Guillaume. Different selective pressures shape the evolution of Toll-like receptors in human and African great ape populations. Human Molecular Genetics. 2013-12-01, roč. 22, čís. 23, s. 4829–4840. Dostupné online [cit. 2020-01-20]. ISSN1460-2083. doi:10.1093/hmg/ddt335. PMID23851028. (anglicky)
BARREIRO, Luis B.; BEN-ALI, Meriem; QUACH, Hélène. Evolutionary Dynamics of Human Toll-Like Receptors and Their Different Contributions to Host Defense. PLoS Genetics. 2009-07-17, roč. 5, čís. 7, s. e1000562. Dostupné online [cit. 2020-01-20]. ISSN1553-7404. doi:10.1371/journal.pgen.1000562. PMID19609346. (anglicky)
PLANTINGA, Theo S.; IOANA, Mihai; ALONSO, Santos. The Evolutionary History of TLR4 Polymorphisms in Europe. Journal of Innate Immunity. 2012, roč. 4, čís. 2, s. 168–175. Dostupné online [cit. 2020-01-20]. ISSN1662-811X. doi:10.1159/000329492. PMID21968286. (anglicky)
RE, Fabio; STROMINGER, Jack L. Monomeric Recombinant MD-2 Binds Toll-like Receptor 4 Tightly and Confers Lipopolysaccharide Responsiveness. Journal of Biological Chemistry. 2002-06-28, roč. 277, čís. 26, s. 23427–23432. Dostupné online [cit. 2020-01-20]. ISSN0021-9258. doi:10.1074/jbc.M202554200. (anglicky)
FITZGERALD, Katherine A.; PALSSON-MCDERMOTT, Eva M.; BOWIE, Andrew G. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature. 2001-09, roč. 413, čís. 6851, s. 78–83. Dostupné online [cit. 2020-01-20]. ISSN0028-0836. doi:10.1038/35092578. (anglicky)
ZHANG, Guolong; GHOSH, Sankar. Negative Regulation of Toll-like Receptor-mediated Signaling by Tollip. Journal of Biological Chemistry. 2002-03-01, roč. 277, čís. 9, s. 7059–7065. Dostupné online [cit. 2020-01-20]. ISSN0021-9258. doi:10.1074/jbc.M109537200. (anglicky)
PEANA, Massimiliano; ZDYB, Karolina; MEDICI, Serenella. Ni(II) interaction with a peptide model of the human TLR4 ectodomain. Journal of Trace Elements in Medicine and Biology. 2017-12, roč. 44, s. 151–160. Dostupné online [cit. 2020-01-20]. doi:10.1016/j.jtemb.2017.07.006. (anglicky)
HUSEBYE, Harald; AUNE, Marie Hjelmseth; STENVIK, Jørgen. The Rab11a GTPase Controls Toll-like Receptor 4-Induced Activation of Interferon Regulatory Factor-3 on Phagosomes. Immunity. 2010-10, roč. 33, čís. 4, s. 583–596. Dostupné online [cit. 2020-01-20]. doi:10.1016/j.immuni.2010.09.010. (anglicky)
SCHRÖDER, Nicolas WJ; SCHUMANN, Ralf R. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. The Lancet Infectious Diseases. 2005-03, roč. 5, čís. 3, s. 156–164. Dostupné online [cit. 2020-01-20]. doi:10.1016/S1473-3099(05)01308-3. (anglicky)
LORENZ, Eva; MIRA, Jean Paul; FREES, Kathy L. Relevance of Mutations in the TLR4 Receptor in Patients With Gram-Negative Septic Shock. Archives of Internal Medicine. 2002-05-13, roč. 162, čís. 9, s. 1028. Dostupné online [cit. 2020-01-20]. ISSN0003-9926. doi:10.1001/archinte.162.9.1028. (anglicky)
NACHTIGALL, Irit; TAMARKIN, Andrey; TAFELSKI, Sascha. Polymorphisms of the toll-like receptor 2 and 4 genes are associated with faster progression and a more severe course of sepsis in critically ill patients. Journal of International Medical Research. 2014-02, roč. 42, čís. 1, s. 93–110. Dostupné online [cit. 2020-01-20]. ISSN0300-0605. doi:10.1177/0300060513504358. (anglicky)
PAL, Durba; DASGUPTA, Suman; KUNDU, Rakesh. Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nature Medicine. 2012-08, roč. 18, čís. 8, s. 1279–1285. Dostupné online [cit. 2020-01-20]. ISSN1078-8956. doi:10.1038/nm.2851. (anglicky)
KORNEEV, Kirill V.; ATRETKHANY, Kamar-Sulu N.; DRUTSKAYA, Marina S. TLR-signaling and proinflammatory cytokines as drivers of tumorigenesis. Cytokine. 2017-01, roč. 89, s. 127–135. Dostupné online [cit. 2020-01-21]. doi:10.1016/j.cyto.2016.01.021. (anglicky)
MOCKENHAUPT, F. P.; CRAMER, J. P.; HAMANN, L. Toll-like receptor (TLR) polymorphisms in African children: Common TLR-4 variants predispose to severe malaria. Proceedings of the National Academy of Sciences. 2006-01-03, roč. 103, čís. 1, s. 177–182. Dostupné online [cit. 2020-01-21]. ISSN0027-8424. doi:10.1073/pnas.0506803102. PMID16371473. (anglicky)
EYKING, Annette; EY, Birgit; RÜNZI, Michael. Toll-like Receptor 4 Variant D299G Induces Features of Neoplastic Progression in Caco-2 Intestinal Cells and Is Associated With Advanced Human Colon Cancer. Gastroenterology. 2011-12, roč. 141, čís. 6, s. 2154–2165. Dostupné online [cit. 2020-01-22]. doi:10.1053/j.gastro.2011.08.043. PMID21920464. (anglicky)
LIU, J.; YANG, A. R.; KELLY, T. Binge alcohol drinking is associated with GABAA 2-regulated Toll-like receptor 4 (TLR4) expression in the central amygdala. Proceedings of the National Academy of Sciences. 2011-03-15, roč. 108, čís. 11, s. 4465–4470. Dostupné online [cit. 2020-01-20]. ISSN0027-8424. doi:10.1073/pnas.1019020108. PMID21368176. (anglicky)
BLANCO, Ana M.; VALLÉS, Soraya L.; PASCUAL, Maria. Involvement of TLR4/Type I IL-1 Receptor Signaling in the Induction of Inflammatory Mediators and Cell Death Induced by Ethanol in Cultured Astrocytes. The Journal of Immunology. 2005-11-15, roč. 175, čís. 10, s. 6893–6899. Dostupné online [cit. 2020-01-20]. ISSN0022-1767. doi:10.4049/jimmunol.175.10.6893. (anglicky)
HAKIM, F.; WANG, Y.; ZHANG, S. X. L. Fragmented Sleep Accelerates Tumor Growth and Progression through Recruitment of Tumor-Associated Macrophages and TLR4 Signaling. Cancer Research. 2014-03-01, roč. 74, čís. 5, s. 1329–1337. Dostupné online [cit. 2020-01-20]. ISSN0008-5472. doi:10.1158/0008-5472.CAN-13-3014. PMID24448240. (anglicky)
MOHAN, Shekher; DAVIS, Randall L.; DESILVA, Udaya. Dual regulation of mu opioid receptors in SK-N-SH neuroblastoma cells by morphine and interleukin-1β: Evidence for opioid-immune crosstalk. Journal of Neuroimmunology. 2010-10, roč. 227, čís. 1–2, s. 26–34. Dostupné online [cit. 2020-01-22]. doi:10.1016/j.jneuroim.2010.06.007. PMID20615556. (anglicky)
KOMATSU, Takaaki; SAKURADA, Shinobu; KATSUYAMA, Sou. Chapter 16 Mechanism of Allodynia Evoked by Intrathecal Morphine‐3‐Glucuronide in Mice. Svazek 85. [s.l.]: Elsevier Dostupné online. ISBN978-0-12-374893-5. doi:10.1016/s0074-7742(09)85016-2. S.207–219. (anglicky) DOI: 10.1016/S0074-7742(09)85016-2.
LEWIS, S.S.; HUTCHINSON, M.R.; REZVANI, N. Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1β. Neuroscience. 2010-01, roč. 165, čís. 2, s. 569–583. Dostupné online [cit. 2020-01-22]. doi:10.1016/j.neuroscience.2009.10.011. PMID19833175. (anglicky)
SHEN, Ching-Hui; TSAI, Ru-Yin; SHIH, Meng-Shen. Etanercept Restores the Antinociceptive Effect of Morphine and Suppresses Spinal Neuroinflammation in Morphine-Tolerant Rats:. Anesthesia & Analgesia. 2011-02, roč. 112, čís. 2, s. 454–459. Dostupné online [cit. 2020-01-22]. ISSN0003-2999. doi:10.1213/ANE.0b013e3182025b15. (anglicky)
HOOK, Michelle A.; WASHBURN, Stephanie N.; MORENO, Georgina. An IL-1 receptor antagonist blocks a morphine-induced attenuation of locomotor recovery after spinal cord injury. Brain, Behavior, and Immunity. 2011-02, roč. 25, čís. 2, s. 349–359. Dostupné online [cit. 2020-01-22]. doi:10.1016/j.bbi.2010.10.018. PMID20974246. (anglicky)
WATKINS, Linda R.; HUTCHINSON, Mark R.; RICE, Kenner C. The “Toll” of Opioid-Induced Glial Activation: Improving the Clinical Efficacy of Opioids by Targeting Glia. Trends in Pharmacological Sciences. 2009-11, roč. 30, čís. 11, s. 581–591. Dostupné online [cit. 2020-01-22]. doi:10.1016/j.tips.2009.08.002. PMID19762094. (anglicky)
HUTCHINSON, Mark R.; ZHANG, Yingning; BROWN, Kimberley. Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4): Naloxone reverses neuropathic pain via TLR4. European Journal of Neuroscience. 2008-07, roč. 28, čís. 1, s. 20–29. Dostupné online [cit. 2020-01-22]. doi:10.1111/j.1460-9568.2008.06321.x. PMID18662331. (anglicky)
HUTCHINSON, Mark R.; COATS, Benjamen D.; LEWIS, Susannah S. Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia. Brain, Behavior, and Immunity. 2008-11, roč. 22, čís. 8, s. 1178–1189. Dostupné online [cit. 2020-01-22]. doi:10.1016/j.bbi.2008.05.004. PMID18599265. (anglicky)
LIN, Shinn-Long; TSAI, Ru-Yin; TAI, Yueh-Hua. Ultra-low dose naloxone upregulates interleukin-10 expression and suppresses neuroinflammation in morphine-tolerant rat spinal cords. Behavioural Brain Research. 2010-02-11, roč. 207, čís. 1, s. 30–36. Dostupné online [cit. 2020-01-22]. doi:10.1016/j.bbr.2009.09.034. (anglicky)
HUTCHINSON, Mark R.; ZHANG, Yingning; SHRIDHAR, Mitesh. Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain, Behavior, and Immunity. 2010-01, roč. 24, čís. 1, s. 83–95. Dostupné online [cit. 2020-01-22]. doi:10.1016/j.bbi.2009.08.004. PMID19679181. (anglicky)
PASCUAL, María; BALIÑO, Pablo; ALFONSO-LOECHES, Silvia. Impact of TLR4 on behavioral and cognitive dysfunctions associated with alcohol-induced neuroinflammatory damage. Brain, Behavior, and Immunity. 2011-06, roč. 25, s. S80–S91. Dostupné online [cit. 2020-01-22]. doi:10.1016/j.bbi.2011.02.012. (anglicky)
HARRIS, Shelley A.; SOLOMON, Keith R. Percutaneous penetration of 2,4‐dichlorophenoxyacetlc acid and 2,4‐d dimethylamine salt in human volunteers. Journal of Toxicology and Environmental Health. 1992-07, roč. 36, čís. 3, s. 233–240. Dostupné online [cit. 2020-01-22]. ISSN0098-4108. doi:10.1080/15287399209531634. (anglicky)
HUTCHINSON, M.R.; LORAM, L.C.; ZHANG, Y. Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activity. Neuroscience. 2010-06, roč. 168, čís. 2, s. 551–563. Dostupné online [cit. 2020-01-22]. doi:10.1016/j.neuroscience.2010.03.067. PMID20381591. (anglicky)
KELLEY, Keith W.; DANTZER, Robert. Alcoholism and inflammation: Neuroimmunology of behavioral and mood disorders. Brain, Behavior, and Immunity. 2011-06, roč. 25, s. S13–S20. Dostupné online [cit. 2020-01-22]. doi:10.1016/j.bbi.2010.12.013. PMID21193024. (anglicky)
TIDSWELL, Mark; TILLIS, William; LAROSA, Steven P. Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis*:. Critical Care Medicine. 2010-01, roč. 38, čís. 1, s. 72–83. Dostupné online [cit. 2020-01-22]. ISSN0090-3493. doi:10.1097/CCM.0b013e3181b07b78. (anglicky)
JIA, Ze-jun; WU, Fei-xiang; HUANG, Qing-hai. [Toll-like receptor 4: the potential therapeutic target for neuropathic pain]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae. 2012-04, roč. 34, čís. 2, s. 168–173. PMID: 22776604. Dostupné online [cit. 2020-01-22]. ISSN1000-503X. doi:10.3881/j.issn.1000-503X.2012.02.013. PMID22776604.
LAN, Xi; HAN, Xiaoning; LI, Qian. Pinocembrin protects hemorrhagic brain primarily by inhibiting toll-like receptor 4 and reducing M1 phenotype microglia. Brain, Behavior, and Immunity. 2017-03, roč. 61, s. 326–339. Dostupné online [cit. 2020-01-22]. doi:10.1016/j.bbi.2016.12.012. PMID28007523. (anglicky)
IMPELLIZZERI, D; CAMPOLO, M; DI PAOLA, R. Ultramicronized palmitoylethanolamide reduces inflammation an a Th1-mediated model of colitis. European Journal of Inflammation. 2015-04, roč. 13, čís. 1, s. 14–31. Dostupné online [cit. 2020-01-22]. ISSN1721-727X. doi:10.1177/1721727X15575869. (anglicky)
dx.doi.org
PARK, B.S.; SONG, D.H.; KIM, H.M. Crystal structure of the human TLR4-human MD-2-E.coli LPS Ra complex. dx.doi.org [online]. 2009-03-03 [cit. 2020-01-19]. Dostupné online.
JULIANA, Bortolatto. Toll-like receptor 4 (TLR4) na modulação da imunidade do tipo 2.. Universidade de Sao Paulo Sistema Integrado de Bibliotecas - SIBiUSP. Dostupné online.
New single-dose drug shortens flu symptoms. AccessScience [online]. [cit. 2020-01-22]. Dostupné online.
LU, Yong-Chen; YEH, Wen-Chen; OHASHI, Pamela S. LPS/TLR4 signal transduction pathway. Cytokine. 2008-05, roč. 42, čís. 2, s. 145–151. Dostupné online [cit. 2020-01-19]. doi:10.1016/j.cyto.2008.01.006. (anglicky)
PEANA, Massimiliano; ZDYB, Karolina; MEDICI, Serenella. Ni(II) interaction with a peptide model of the human TLR4 ectodomain. Journal of Trace Elements in Medicine and Biology. 2017-12, roč. 44, s. 151–160. Dostupné online [cit. 2020-01-20]. doi:10.1016/j.jtemb.2017.07.006. (anglicky)
HUSEBYE, Harald; AUNE, Marie Hjelmseth; STENVIK, Jørgen. The Rab11a GTPase Controls Toll-like Receptor 4-Induced Activation of Interferon Regulatory Factor-3 on Phagosomes. Immunity. 2010-10, roč. 33, čís. 4, s. 583–596. Dostupné online [cit. 2020-01-20]. doi:10.1016/j.immuni.2010.09.010. (anglicky)
SCHRÖDER, Nicolas WJ; SCHUMANN, Ralf R. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. The Lancet Infectious Diseases. 2005-03, roč. 5, čís. 3, s. 156–164. Dostupné online [cit. 2020-01-20]. doi:10.1016/S1473-3099(05)01308-3. (anglicky)
KORNEEV, Kirill V.; ATRETKHANY, Kamar-Sulu N.; DRUTSKAYA, Marina S. TLR-signaling and proinflammatory cytokines as drivers of tumorigenesis. Cytokine. 2017-01, roč. 89, s. 127–135. Dostupné online [cit. 2020-01-21]. doi:10.1016/j.cyto.2016.01.021. (anglicky)
EYKING, Annette; EY, Birgit; RÜNZI, Michael. Toll-like Receptor 4 Variant D299G Induces Features of Neoplastic Progression in Caco-2 Intestinal Cells and Is Associated With Advanced Human Colon Cancer. Gastroenterology. 2011-12, roč. 141, čís. 6, s. 2154–2165. Dostupné online [cit. 2020-01-22]. doi:10.1053/j.gastro.2011.08.043. PMID21920464. (anglicky)
MOHAN, Shekher; DAVIS, Randall L.; DESILVA, Udaya. Dual regulation of mu opioid receptors in SK-N-SH neuroblastoma cells by morphine and interleukin-1β: Evidence for opioid-immune crosstalk. Journal of Neuroimmunology. 2010-10, roč. 227, čís. 1–2, s. 26–34. Dostupné online [cit. 2020-01-22]. doi:10.1016/j.jneuroim.2010.06.007. PMID20615556. (anglicky)
KOMATSU, Takaaki; SAKURADA, Shinobu; KATSUYAMA, Sou. Chapter 16 Mechanism of Allodynia Evoked by Intrathecal Morphine‐3‐Glucuronide in Mice. Svazek 85. [s.l.]: Elsevier Dostupné online. ISBN978-0-12-374893-5. doi:10.1016/s0074-7742(09)85016-2. S.207–219. (anglicky) DOI: 10.1016/S0074-7742(09)85016-2.
LEWIS, S.S.; HUTCHINSON, M.R.; REZVANI, N. Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1β. Neuroscience. 2010-01, roč. 165, čís. 2, s. 569–583. Dostupné online [cit. 2020-01-22]. doi:10.1016/j.neuroscience.2009.10.011. PMID19833175. (anglicky)
HOOK, Michelle A.; WASHBURN, Stephanie N.; MORENO, Georgina. An IL-1 receptor antagonist blocks a morphine-induced attenuation of locomotor recovery after spinal cord injury. Brain, Behavior, and Immunity. 2011-02, roč. 25, čís. 2, s. 349–359. Dostupné online [cit. 2020-01-22]. doi:10.1016/j.bbi.2010.10.018. PMID20974246. (anglicky)
WATKINS, Linda R.; HUTCHINSON, Mark R.; RICE, Kenner C. The “Toll” of Opioid-Induced Glial Activation: Improving the Clinical Efficacy of Opioids by Targeting Glia. Trends in Pharmacological Sciences. 2009-11, roč. 30, čís. 11, s. 581–591. Dostupné online [cit. 2020-01-22]. doi:10.1016/j.tips.2009.08.002. PMID19762094. (anglicky)
HUTCHINSON, Mark R.; COATS, Benjamen D.; LEWIS, Susannah S. Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia. Brain, Behavior, and Immunity. 2008-11, roč. 22, čís. 8, s. 1178–1189. Dostupné online [cit. 2020-01-22]. doi:10.1016/j.bbi.2008.05.004. PMID18599265. (anglicky)
LIN, Shinn-Long; TSAI, Ru-Yin; TAI, Yueh-Hua. Ultra-low dose naloxone upregulates interleukin-10 expression and suppresses neuroinflammation in morphine-tolerant rat spinal cords. Behavioural Brain Research. 2010-02-11, roč. 207, čís. 1, s. 30–36. Dostupné online [cit. 2020-01-22]. doi:10.1016/j.bbr.2009.09.034. (anglicky)
HUTCHINSON, Mark R.; ZHANG, Yingning; SHRIDHAR, Mitesh. Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain, Behavior, and Immunity. 2010-01, roč. 24, čís. 1, s. 83–95. Dostupné online [cit. 2020-01-22]. doi:10.1016/j.bbi.2009.08.004. PMID19679181. (anglicky)
PASCUAL, María; BALIÑO, Pablo; ALFONSO-LOECHES, Silvia. Impact of TLR4 on behavioral and cognitive dysfunctions associated with alcohol-induced neuroinflammatory damage. Brain, Behavior, and Immunity. 2011-06, roč. 25, s. S80–S91. Dostupné online [cit. 2020-01-22]. doi:10.1016/j.bbi.2011.02.012. (anglicky)
HUTCHINSON, M.R.; LORAM, L.C.; ZHANG, Y. Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activity. Neuroscience. 2010-06, roč. 168, čís. 2, s. 551–563. Dostupné online [cit. 2020-01-22]. doi:10.1016/j.neuroscience.2010.03.067. PMID20381591. (anglicky)
KELLEY, Keith W.; DANTZER, Robert. Alcoholism and inflammation: Neuroimmunology of behavioral and mood disorders. Brain, Behavior, and Immunity. 2011-06, roč. 25, s. S13–S20. Dostupné online [cit. 2020-01-22]. doi:10.1016/j.bbi.2010.12.013. PMID21193024. (anglicky)
LAN, Xi; HAN, Xiaoning; LI, Qian. Pinocembrin protects hemorrhagic brain primarily by inhibiting toll-like receptor 4 and reducing M1 phenotype microglia. Brain, Behavior, and Immunity. 2017-03, roč. 61, s. 326–339. Dostupné online [cit. 2020-01-22]. doi:10.1016/j.bbi.2016.12.012. PMID28007523. (anglicky)
LORENZ, Eva; MIRA, Jean Paul; FREES, Kathy L. Relevance of Mutations in the TLR4 Receptor in Patients With Gram-Negative Septic Shock. Archives of Internal Medicine. 2002-05-13, roč. 162, čís. 9, s. 1028. Dostupné online [cit. 2020-01-20]. ISSN0003-9926. doi:10.1001/archinte.162.9.1028. (anglicky)
BLANCO, Ana M.; VALLÉS, Soraya L.; PASCUAL, Maria. Involvement of TLR4/Type I IL-1 Receptor Signaling in the Induction of Inflammatory Mediators and Cell Death Induced by Ethanol in Cultured Astrocytes. The Journal of Immunology. 2005-11-15, roč. 175, čís. 10, s. 6893–6899. Dostupné online [cit. 2020-01-20]. ISSN0022-1767. doi:10.4049/jimmunol.175.10.6893. (anglicky)
PLANTINGA, Theo S.; IOANA, Mihai; ALONSO, Santos. The Evolutionary History of TLR4 Polymorphisms in Europe. Journal of Innate Immunity. 2012, roč. 4, čís. 2, s. 168–175. Dostupné online [cit. 2020-01-20]. ISSN1662-811X. doi:10.1159/000329492. PMID21968286. (anglicky)
O'NEILL, Luke A. J.; GOLENBOCK, Douglas; BOWIE, Andrew G. The history of Toll-like receptors — redefining innate immunity. Nature Reviews Immunology. 2013-06, roč. 13, čís. 6, s. 453–460. Dostupné online [cit. 2020-01-20]. ISSN1474-1733. doi:10.1038/nri3446. (anglicky)
FITZGERALD, Katherine A.; PALSSON-MCDERMOTT, Eva M.; BOWIE, Andrew G. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature. 2001-09, roč. 413, čís. 6851, s. 78–83. Dostupné online [cit. 2020-01-20]. ISSN0028-0836. doi:10.1038/35092578. (anglicky)
PAL, Durba; DASGUPTA, Suman; KUNDU, Rakesh. Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nature Medicine. 2012-08, roč. 18, čís. 8, s. 1279–1285. Dostupné online [cit. 2020-01-20]. ISSN1078-8956. doi:10.1038/nm.2851. (anglicky)
QUACH, Hélène; WILSON, Daniel; LAVAL, Guillaume. Different selective pressures shape the evolution of Toll-like receptors in human and African great ape populations. Human Molecular Genetics. 2013-12-01, roč. 22, čís. 23, s. 4829–4840. Dostupné online [cit. 2020-01-20]. ISSN1460-2083. doi:10.1093/hmg/ddt335. PMID23851028. (anglicky)
BARREIRO, Luis B.; BEN-ALI, Meriem; QUACH, Hélène. Evolutionary Dynamics of Human Toll-Like Receptors and Their Different Contributions to Host Defense. PLoS Genetics. 2009-07-17, roč. 5, čís. 7, s. e1000562. Dostupné online [cit. 2020-01-20]. ISSN1553-7404. doi:10.1371/journal.pgen.1000562. PMID19609346. (anglicky)
PLANTINGA, Theo S.; IOANA, Mihai; ALONSO, Santos. The Evolutionary History of TLR4 Polymorphisms in Europe. Journal of Innate Immunity. 2012, roč. 4, čís. 2, s. 168–175. Dostupné online [cit. 2020-01-20]. ISSN1662-811X. doi:10.1159/000329492. PMID21968286. (anglicky)
MOCKENHAUPT, F. P.; CRAMER, J. P.; HAMANN, L. Toll-like receptor (TLR) polymorphisms in African children: Common TLR-4 variants predispose to severe malaria. Proceedings of the National Academy of Sciences. 2006-01-03, roč. 103, čís. 1, s. 177–182. Dostupné online [cit. 2020-01-21]. ISSN0027-8424. doi:10.1073/pnas.0506803102. PMID16371473. (anglicky)
VAN DER GRAAF, Chantal A. A.; NETEA, Mihai G.; MORRÉ, Servaas A. Toll-like receptor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection. European Cytokine Network. 2006-03, roč. 17, čís. 1, s. 29–34. PMID: 16613760. Dostupné online [cit. 2020-01-21]. ISSN1148-5493. PMID16613760.
EYKING, Annette; EY, Birgit; RÜNZI, Michael. Toll-like Receptor 4 Variant D299G Induces Features of Neoplastic Progression in Caco-2 Intestinal Cells and Is Associated With Advanced Human Colon Cancer. Gastroenterology. 2011-12, roč. 141, čís. 6, s. 2154–2165. Dostupné online [cit. 2020-01-22]. doi:10.1053/j.gastro.2011.08.043. PMID21920464. (anglicky)
LIU, J.; YANG, A. R.; KELLY, T. Binge alcohol drinking is associated with GABAA 2-regulated Toll-like receptor 4 (TLR4) expression in the central amygdala. Proceedings of the National Academy of Sciences. 2011-03-15, roč. 108, čís. 11, s. 4465–4470. Dostupné online [cit. 2020-01-20]. ISSN0027-8424. doi:10.1073/pnas.1019020108. PMID21368176. (anglicky)
HAKIM, F.; WANG, Y.; ZHANG, S. X. L. Fragmented Sleep Accelerates Tumor Growth and Progression through Recruitment of Tumor-Associated Macrophages and TLR4 Signaling. Cancer Research. 2014-03-01, roč. 74, čís. 5, s. 1329–1337. Dostupné online [cit. 2020-01-20]. ISSN0008-5472. doi:10.1158/0008-5472.CAN-13-3014. PMID24448240. (anglicky)
MOHAN, Shekher; DAVIS, Randall L.; DESILVA, Udaya. Dual regulation of mu opioid receptors in SK-N-SH neuroblastoma cells by morphine and interleukin-1β: Evidence for opioid-immune crosstalk. Journal of Neuroimmunology. 2010-10, roč. 227, čís. 1–2, s. 26–34. Dostupné online [cit. 2020-01-22]. doi:10.1016/j.jneuroim.2010.06.007. PMID20615556. (anglicky)
LEWIS, S.S.; HUTCHINSON, M.R.; REZVANI, N. Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1β. Neuroscience. 2010-01, roč. 165, čís. 2, s. 569–583. Dostupné online [cit. 2020-01-22]. doi:10.1016/j.neuroscience.2009.10.011. PMID19833175. (anglicky)
HOOK, Michelle A.; WASHBURN, Stephanie N.; MORENO, Georgina. An IL-1 receptor antagonist blocks a morphine-induced attenuation of locomotor recovery after spinal cord injury. Brain, Behavior, and Immunity. 2011-02, roč. 25, čís. 2, s. 349–359. Dostupné online [cit. 2020-01-22]. doi:10.1016/j.bbi.2010.10.018. PMID20974246. (anglicky)
WATKINS, Linda R.; HUTCHINSON, Mark R.; RICE, Kenner C. The “Toll” of Opioid-Induced Glial Activation: Improving the Clinical Efficacy of Opioids by Targeting Glia. Trends in Pharmacological Sciences. 2009-11, roč. 30, čís. 11, s. 581–591. Dostupné online [cit. 2020-01-22]. doi:10.1016/j.tips.2009.08.002. PMID19762094. (anglicky)
HUTCHINSON, Mark R.; ZHANG, Yingning; BROWN, Kimberley. Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4): Naloxone reverses neuropathic pain via TLR4. European Journal of Neuroscience. 2008-07, roč. 28, čís. 1, s. 20–29. Dostupné online [cit. 2020-01-22]. doi:10.1111/j.1460-9568.2008.06321.x. PMID18662331. (anglicky)
HUTCHINSON, Mark R.; COATS, Benjamen D.; LEWIS, Susannah S. Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia. Brain, Behavior, and Immunity. 2008-11, roč. 22, čís. 8, s. 1178–1189. Dostupné online [cit. 2020-01-22]. doi:10.1016/j.bbi.2008.05.004. PMID18599265. (anglicky)
HUTCHINSON, Mark R.; ZHANG, Yingning; SHRIDHAR, Mitesh. Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain, Behavior, and Immunity. 2010-01, roč. 24, čís. 1, s. 83–95. Dostupné online [cit. 2020-01-22]. doi:10.1016/j.bbi.2009.08.004. PMID19679181. (anglicky)
HUTCHINSON, M.R.; LORAM, L.C.; ZHANG, Y. Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activity. Neuroscience. 2010-06, roč. 168, čís. 2, s. 551–563. Dostupné online [cit. 2020-01-22]. doi:10.1016/j.neuroscience.2010.03.067. PMID20381591. (anglicky)
KELLEY, Keith W.; DANTZER, Robert. Alcoholism and inflammation: Neuroimmunology of behavioral and mood disorders. Brain, Behavior, and Immunity. 2011-06, roč. 25, s. S13–S20. Dostupné online [cit. 2020-01-22]. doi:10.1016/j.bbi.2010.12.013. PMID21193024. (anglicky)
JIA, Ze-jun; WU, Fei-xiang; HUANG, Qing-hai. [Toll-like receptor 4: the potential therapeutic target for neuropathic pain]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae. 2012-04, roč. 34, čís. 2, s. 168–173. PMID: 22776604. Dostupné online [cit. 2020-01-22]. ISSN1000-503X. doi:10.3881/j.issn.1000-503X.2012.02.013. PMID22776604.
LAN, Xi; HAN, Xiaoning; LI, Qian. Pinocembrin protects hemorrhagic brain primarily by inhibiting toll-like receptor 4 and reducing M1 phenotype microglia. Brain, Behavior, and Immunity. 2017-03, roč. 61, s. 326–339. Dostupné online [cit. 2020-01-22]. doi:10.1016/j.bbi.2016.12.012. PMID28007523. (anglicky)
QUACH, Hélène; WILSON, Daniel; LAVAL, Guillaume. Different selective pressures shape the evolution of Toll-like receptors in human and African great ape populations. Human Molecular Genetics. 2013-12-01, roč. 22, čís. 23, s. 4829–4840. Dostupné online [cit. 2020-01-20]. ISSN1460-2083. doi:10.1093/hmg/ddt335. PMID23851028. (anglicky)
SHEN, Ching-Hui; TSAI, Ru-Yin; SHIH, Meng-Shen. Etanercept Restores the Antinociceptive Effect of Morphine and Suppresses Spinal Neuroinflammation in Morphine-Tolerant Rats:. Anesthesia & Analgesia. 2011-02, roč. 112, čís. 2, s. 454–459. Dostupné online [cit. 2020-01-22]. ISSN0003-2999. doi:10.1213/ANE.0b013e3182025b15. (anglicky)
TIDSWELL, Mark; TILLIS, William; LAROSA, Steven P. Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis*:. Critical Care Medicine. 2010-01, roč. 38, čís. 1, s. 72–83. Dostupné online [cit. 2020-01-22]. ISSN0090-3493. doi:10.1097/CCM.0b013e3181b07b78. (anglicky)
BARREIRO, Luis B.; BEN-ALI, Meriem; QUACH, Hélène. Evolutionary Dynamics of Human Toll-Like Receptors and Their Different Contributions to Host Defense. PLoS Genetics. 2009-07-17, roč. 5, čís. 7, s. e1000562. Dostupné online [cit. 2020-01-20]. ISSN1553-7404. doi:10.1371/journal.pgen.1000562. PMID19609346. (anglicky)
MOCKENHAUPT, F. P.; CRAMER, J. P.; HAMANN, L. Toll-like receptor (TLR) polymorphisms in African children: Common TLR-4 variants predispose to severe malaria. Proceedings of the National Academy of Sciences. 2006-01-03, roč. 103, čís. 1, s. 177–182. Dostupné online [cit. 2020-01-21]. ISSN0027-8424. doi:10.1073/pnas.0506803102. PMID16371473. (anglicky)
LIU, J.; YANG, A. R.; KELLY, T. Binge alcohol drinking is associated with GABAA 2-regulated Toll-like receptor 4 (TLR4) expression in the central amygdala. Proceedings of the National Academy of Sciences. 2011-03-15, roč. 108, čís. 11, s. 4465–4470. Dostupné online [cit. 2020-01-20]. ISSN0027-8424. doi:10.1073/pnas.1019020108. PMID21368176. (anglicky)
NACHTIGALL, Irit; TAMARKIN, Andrey; TAFELSKI, Sascha. Polymorphisms of the toll-like receptor 2 and 4 genes are associated with faster progression and a more severe course of sepsis in critically ill patients. Journal of International Medical Research. 2014-02, roč. 42, čís. 1, s. 93–110. Dostupné online [cit. 2020-01-20]. ISSN0300-0605. doi:10.1177/0300060513504358. (anglicky)
IMPELLIZZERI, D; CAMPOLO, M; DI PAOLA, R. Ultramicronized palmitoylethanolamide reduces inflammation an a Th1-mediated model of colitis. European Journal of Inflammation. 2015-04, roč. 13, čís. 1, s. 14–31. Dostupné online [cit. 2020-01-22]. ISSN1721-727X. doi:10.1177/1721727X15575869. (anglicky)
BEUTLER, B.; REHLI, M. Evolution of the TIR, Tolls and TLRs: Functional Inferences from Computational Biology. Příprava vydání Bruce Beutler, Hermann Wagner. Svazek 270. Berlin, Heidelberg: Springer Berlin Heidelberg Dostupné online. ISBN978-3-642-63975-3, ISBN978-3-642-59430-4. doi:10.1007/978-3-642-59430-4_1. S.1–21. DOI: 10.1007/978-3-642-59430-4_1.
HARRIS, Shelley A.; SOLOMON, Keith R. Percutaneous penetration of 2,4‐dichlorophenoxyacetlc acid and 2,4‐d dimethylamine salt in human volunteers. Journal of Toxicology and Environmental Health. 1992-07, roč. 36, čís. 3, s. 233–240. Dostupné online [cit. 2020-01-22]. ISSN0098-4108. doi:10.1080/15287399209531634. (anglicky)
O'NEILL, Luke A. J.; GOLENBOCK, Douglas; BOWIE, Andrew G. The history of Toll-like receptors — redefining innate immunity. Nature Reviews Immunology. 2013-06, roč. 13, čís. 6, s. 453–460. Dostupné online [cit. 2020-01-20]. ISSN1474-1733. doi:10.1038/nri3446. (anglicky)
QUACH, Hélène; WILSON, Daniel; LAVAL, Guillaume. Different selective pressures shape the evolution of Toll-like receptors in human and African great ape populations. Human Molecular Genetics. 2013-12-01, roč. 22, čís. 23, s. 4829–4840. Dostupné online [cit. 2020-01-20]. ISSN1460-2083. doi:10.1093/hmg/ddt335. PMID23851028. (anglicky)
BARREIRO, Luis B.; BEN-ALI, Meriem; QUACH, Hélène. Evolutionary Dynamics of Human Toll-Like Receptors and Their Different Contributions to Host Defense. PLoS Genetics. 2009-07-17, roč. 5, čís. 7, s. e1000562. Dostupné online [cit. 2020-01-20]. ISSN1553-7404. doi:10.1371/journal.pgen.1000562. PMID19609346. (anglicky)
PLANTINGA, Theo S.; IOANA, Mihai; ALONSO, Santos. The Evolutionary History of TLR4 Polymorphisms in Europe. Journal of Innate Immunity. 2012, roč. 4, čís. 2, s. 168–175. Dostupné online [cit. 2020-01-20]. ISSN1662-811X. doi:10.1159/000329492. PMID21968286. (anglicky)
RE, Fabio; STROMINGER, Jack L. Monomeric Recombinant MD-2 Binds Toll-like Receptor 4 Tightly and Confers Lipopolysaccharide Responsiveness. Journal of Biological Chemistry. 2002-06-28, roč. 277, čís. 26, s. 23427–23432. Dostupné online [cit. 2020-01-20]. ISSN0021-9258. doi:10.1074/jbc.M202554200. (anglicky)
FITZGERALD, Katherine A.; PALSSON-MCDERMOTT, Eva M.; BOWIE, Andrew G. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature. 2001-09, roč. 413, čís. 6851, s. 78–83. Dostupné online [cit. 2020-01-20]. ISSN0028-0836. doi:10.1038/35092578. (anglicky)
ZHANG, Guolong; GHOSH, Sankar. Negative Regulation of Toll-like Receptor-mediated Signaling by Tollip. Journal of Biological Chemistry. 2002-03-01, roč. 277, čís. 9, s. 7059–7065. Dostupné online [cit. 2020-01-20]. ISSN0021-9258. doi:10.1074/jbc.M109537200. (anglicky)
LORENZ, Eva; MIRA, Jean Paul; FREES, Kathy L. Relevance of Mutations in the TLR4 Receptor in Patients With Gram-Negative Septic Shock. Archives of Internal Medicine. 2002-05-13, roč. 162, čís. 9, s. 1028. Dostupné online [cit. 2020-01-20]. ISSN0003-9926. doi:10.1001/archinte.162.9.1028. (anglicky)
NACHTIGALL, Irit; TAMARKIN, Andrey; TAFELSKI, Sascha. Polymorphisms of the toll-like receptor 2 and 4 genes are associated with faster progression and a more severe course of sepsis in critically ill patients. Journal of International Medical Research. 2014-02, roč. 42, čís. 1, s. 93–110. Dostupné online [cit. 2020-01-20]. ISSN0300-0605. doi:10.1177/0300060513504358. (anglicky)
PAL, Durba; DASGUPTA, Suman; KUNDU, Rakesh. Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nature Medicine. 2012-08, roč. 18, čís. 8, s. 1279–1285. Dostupné online [cit. 2020-01-20]. ISSN1078-8956. doi:10.1038/nm.2851. (anglicky)
MOCKENHAUPT, F. P.; CRAMER, J. P.; HAMANN, L. Toll-like receptor (TLR) polymorphisms in African children: Common TLR-4 variants predispose to severe malaria. Proceedings of the National Academy of Sciences. 2006-01-03, roč. 103, čís. 1, s. 177–182. Dostupné online [cit. 2020-01-21]. ISSN0027-8424. doi:10.1073/pnas.0506803102. PMID16371473. (anglicky)
VAN DER GRAAF, Chantal A. A.; NETEA, Mihai G.; MORRÉ, Servaas A. Toll-like receptor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection. European Cytokine Network. 2006-03, roč. 17, čís. 1, s. 29–34. PMID: 16613760. Dostupné online [cit. 2020-01-21]. ISSN1148-5493. PMID16613760.
LIU, J.; YANG, A. R.; KELLY, T. Binge alcohol drinking is associated with GABAA 2-regulated Toll-like receptor 4 (TLR4) expression in the central amygdala. Proceedings of the National Academy of Sciences. 2011-03-15, roč. 108, čís. 11, s. 4465–4470. Dostupné online [cit. 2020-01-20]. ISSN0027-8424. doi:10.1073/pnas.1019020108. PMID21368176. (anglicky)
BLANCO, Ana M.; VALLÉS, Soraya L.; PASCUAL, Maria. Involvement of TLR4/Type I IL-1 Receptor Signaling in the Induction of Inflammatory Mediators and Cell Death Induced by Ethanol in Cultured Astrocytes. The Journal of Immunology. 2005-11-15, roč. 175, čís. 10, s. 6893–6899. Dostupné online [cit. 2020-01-20]. ISSN0022-1767. doi:10.4049/jimmunol.175.10.6893. (anglicky)
HAKIM, F.; WANG, Y.; ZHANG, S. X. L. Fragmented Sleep Accelerates Tumor Growth and Progression through Recruitment of Tumor-Associated Macrophages and TLR4 Signaling. Cancer Research. 2014-03-01, roč. 74, čís. 5, s. 1329–1337. Dostupné online [cit. 2020-01-20]. ISSN0008-5472. doi:10.1158/0008-5472.CAN-13-3014. PMID24448240. (anglicky)
HARRIS, Shelley A.; SOLOMON, Keith R. Percutaneous penetration of 2,4‐dichlorophenoxyacetlc acid and 2,4‐d dimethylamine salt in human volunteers. Journal of Toxicology and Environmental Health. 1992-07, roč. 36, čís. 3, s. 233–240. Dostupné online [cit. 2020-01-22]. ISSN0098-4108. doi:10.1080/15287399209531634. (anglicky)
TIDSWELL, Mark; TILLIS, William; LAROSA, Steven P. Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis*:. Critical Care Medicine. 2010-01, roč. 38, čís. 1, s. 72–83. Dostupné online [cit. 2020-01-22]. ISSN0090-3493. doi:10.1097/CCM.0b013e3181b07b78. (anglicky)
JIA, Ze-jun; WU, Fei-xiang; HUANG, Qing-hai. [Toll-like receptor 4: the potential therapeutic target for neuropathic pain]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae. 2012-04, roč. 34, čís. 2, s. 168–173. PMID: 22776604. Dostupné online [cit. 2020-01-22]. ISSN1000-503X. doi:10.3881/j.issn.1000-503X.2012.02.013. PMID22776604.
IMPELLIZZERI, D; CAMPOLO, M; DI PAOLA, R. Ultramicronized palmitoylethanolamide reduces inflammation an a Th1-mediated model of colitis. European Journal of Inflammation. 2015-04, roč. 13, čís. 1, s. 14–31. Dostupné online [cit. 2020-01-22]. ISSN1721-727X. doi:10.1177/1721727X15575869. (anglicky)